

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | striated muscle atrophy (GO:0014891) | 9.86151693 |
| 2 | skeletal muscle adaptation (GO:0043501) | 9.85577939 |
| 3 | muscle atrophy (GO:0014889) | 9.33397201 |
| 4 | response to gravity (GO:0009629) | 9.17364110 |
| 5 | negative regulation of muscle hypertrophy (GO:0014741) | 7.34353805 |
| 6 | skeletal muscle tissue regeneration (GO:0043403) | 6.83143050 |
| 7 | muscle filament sliding (GO:0030049) | 6.53143370 |
| 8 | actin-myosin filament sliding (GO:0033275) | 6.53143370 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 6.11147226 |
| 10 | response to muscle activity (GO:0014850) | 5.90667436 |
| 11 | negative regulation of skeletal muscle tissue development (GO:0048642) | 5.70368744 |
| 12 | actin-mediated cell contraction (GO:0070252) | 5.64121387 |
| 13 | cellular response to dexamethasone stimulus (GO:0071549) | 4.75179470 |
| 14 | platelet dense granule organization (GO:0060155) | 4.72555978 |
| 15 | response to activity (GO:0014823) | 4.63839153 |
| 16 | appendage development (GO:0048736) | 4.57676688 |
| 17 | limb development (GO:0060173) | 4.57676688 |
| 18 | response to dexamethasone (GO:0071548) | 4.38854571 |
| 19 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.35161716 |
| 20 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.35161716 |
| 21 | actin filament-based movement (GO:0030048) | 4.32892917 |
| 22 | striated muscle adaptation (GO:0014888) | 4.28198424 |
| 23 | dendritic spine morphogenesis (GO:0060997) | 4.15034616 |
| 24 | protein K6-linked ubiquitination (GO:0085020) | 4.02079348 |
| 25 | nonmotile primary cilium assembly (GO:0035058) | 3.93155713 |
| 26 | secretory granule organization (GO:0033363) | 3.91116357 |
| 27 | cullin deneddylation (GO:0010388) | 3.87740637 |
| 28 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.85748553 |
| 29 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.85748553 |
| 30 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.85748553 |
| 31 | histone mRNA catabolic process (GO:0071044) | 3.70357987 |
| 32 | intraciliary transport (GO:0042073) | 3.58451534 |
| 33 | muscle adaptation (GO:0043500) | 3.46701585 |
| 34 | anterograde synaptic vesicle transport (GO:0048490) | 3.41332391 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39551754 |
| 36 | behavioral response to nicotine (GO:0035095) | 3.36752122 |
| 37 | regulation of muscle hypertrophy (GO:0014743) | 3.35299585 |
| 38 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.32126223 |
| 39 | muscle organ development (GO:0007517) | 3.31866370 |
| 40 | response to electrical stimulus (GO:0051602) | 3.29021954 |
| 41 | pantothenate metabolic process (GO:0015939) | 3.24651667 |
| 42 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.23365406 |
| 43 | chaperone-mediated protein complex assembly (GO:0051131) | 3.22825470 |
| 44 | muscle structure development (GO:0061061) | 3.22578479 |
| 45 | positive regulation of gastrulation (GO:2000543) | 3.17901467 |
| 46 | biotin metabolic process (GO:0006768) | 3.14711493 |
| 47 | mature B cell differentiation (GO:0002335) | 3.14412575 |
| 48 | retinal ganglion cell axon guidance (GO:0031290) | 3.14208331 |
| 49 | protein deneddylation (GO:0000338) | 3.10107122 |
| 50 | nucleobase catabolic process (GO:0046113) | 3.08413623 |
| 51 | dosage compensation (GO:0007549) | 3.00587800 |
| 52 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.97276493 |
| 53 | DNA demethylation (GO:0080111) | 2.97138246 |
| 54 | cellular response to corticosteroid stimulus (GO:0071384) | 2.96584606 |
| 55 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.96402888 |
| 56 | protein localization to chromosome, centromeric region (GO:0071459) | 2.92675140 |
| 57 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.92063111 |
| 58 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.92051493 |
| 59 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.88198229 |
| 60 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.88198229 |
| 61 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.88198229 |
| 62 | regulation of centriole replication (GO:0046599) | 2.87439537 |
| 63 | regulation of receptor binding (GO:1900120) | 2.87420898 |
| 64 | radial glial cell differentiation (GO:0060019) | 2.87265996 |
| 65 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.86209320 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 2.84230060 |
| 67 | skeletal muscle contraction (GO:0003009) | 2.84042676 |
| 68 | regulation of action potential (GO:0098900) | 2.79153452 |
| 69 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.78207909 |
| 70 | DNA dealkylation (GO:0035510) | 2.77194359 |
| 71 | protein localization to kinetochore (GO:0034501) | 2.73116131 |
| 72 | tissue regeneration (GO:0042246) | 2.71606964 |
| 73 | cytidine metabolic process (GO:0046087) | 2.70744479 |
| 74 | cytidine catabolic process (GO:0006216) | 2.70744479 |
| 75 | cytidine deamination (GO:0009972) | 2.70744479 |
| 76 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.69581106 |
| 77 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.69581106 |
| 78 | metaphase plate congression (GO:0051310) | 2.68847645 |
| 79 | ncRNA catabolic process (GO:0034661) | 2.63555738 |
| 80 | olfactory bulb development (GO:0021772) | 2.63373875 |
| 81 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.63272184 |
| 82 | cranial nerve morphogenesis (GO:0021602) | 2.61900054 |
| 83 | response to inactivity (GO:0014854) | 2.61295902 |
| 84 | dentate gyrus development (GO:0021542) | 2.61060103 |
| 85 | response to folic acid (GO:0051593) | 2.60866416 |
| 86 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.58505256 |
| 87 | negative regulation of mast cell activation (GO:0033004) | 2.55916370 |
| 88 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.54386412 |
| 89 | protein localization to cilium (GO:0061512) | 2.54363579 |
| 90 | melanosome organization (GO:0032438) | 2.52912076 |
| 91 | neurotransmitter catabolic process (GO:0042135) | 2.52132114 |
| 92 | central nervous system neuron axonogenesis (GO:0021955) | 2.51797512 |
| 93 | muscle organ morphogenesis (GO:0048644) | 2.49485587 |
| 94 | cellular ketone body metabolic process (GO:0046950) | 2.47926471 |
| 95 | negative regulation of organelle assembly (GO:1902116) | 2.46364139 |
| 96 | cardiac ventricle formation (GO:0003211) | 2.45183415 |
| 97 | insulin secretion (GO:0030073) | 2.44268026 |
| 98 | glial cell proliferation (GO:0014009) | 2.44224627 |
| 99 | neurotransmitter biosynthetic process (GO:0042136) | 2.42368041 |
| 100 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.41985371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.69847753 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 5.22596266 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.75193128 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.87010881 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.83074221 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.79917689 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.78306653 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68779428 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.61896350 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.57769223 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.53096352 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.42090009 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.38173484 |
| 14 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.04091831 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00089793 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.98692994 |
| 17 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.95164216 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.94806964 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.92724244 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.91940500 |
| 21 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.88631815 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87581235 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85366006 |
| 24 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.82627051 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79195556 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78112541 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.76315651 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72150107 |
| 29 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.72021358 |
| 30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.65617717 |
| 31 | P300_19829295_ChIP-Seq_ESCs_Human | 1.58285877 |
| 32 | STAT3_23295773_ChIP-Seq_U87_Human | 1.57261486 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56392230 |
| 34 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.53301097 |
| 35 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.53301097 |
| 36 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52087875 |
| 37 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.52087875 |
| 38 | TCF4_23295773_ChIP-Seq_U87_Human | 1.50402730 |
| 39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.50287860 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49365168 |
| 41 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.48631178 |
| 42 | RXR_22108803_ChIP-Seq_LS180_Human | 1.47072741 |
| 43 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45980199 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45773697 |
| 45 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.41573482 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40375676 |
| 47 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.38183247 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.37673012 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36828133 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.32915803 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32776155 |
| 52 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.28437688 |
| 53 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28366780 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26985376 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26865349 |
| 56 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.26288338 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25989755 |
| 58 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25556076 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24222980 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21645206 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.21466548 |
| 62 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.20282545 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20101627 |
| 64 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19313522 |
| 65 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.19283556 |
| 66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.18594563 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18075567 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17699761 |
| 69 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.16948636 |
| 70 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13715626 |
| 71 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.13368617 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12336944 |
| 73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11554249 |
| 74 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.10902699 |
| 75 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10754632 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07556416 |
| 77 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07211410 |
| 78 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.06612129 |
| 79 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05574289 |
| 80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.05142782 |
| 81 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04557107 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03301819 |
| 83 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99863860 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99145627 |
| 85 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.98243968 |
| 86 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98076927 |
| 87 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97118383 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96785812 |
| 89 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.96345236 |
| 90 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95997999 |
| 91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95808889 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95560642 |
| 93 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94180069 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93936389 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92249401 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91884119 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91178932 |
| 98 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91129193 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90342139 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88284750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 8.08426393 |
| 2 | MP0003787_abnormal_imprinting | 4.74634297 |
| 3 | MP0002638_abnormal_pupillary_reflex | 4.57327333 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 4.43465669 |
| 5 | MP0000747_muscle_weakness | 3.21267293 |
| 6 | MP0005171_absent_coat_pigmentation | 2.87459563 |
| 7 | MP0000749_muscle_degeneration | 2.83549471 |
| 8 | MP0002822_catalepsy | 2.54333114 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.37217646 |
| 10 | MP0002269_muscular_atrophy | 2.35285834 |
| 11 | MP0006276_abnormal_autonomic_nervous | 2.31096553 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.25888900 |
| 13 | MP0003121_genomic_imprinting | 2.20675743 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.10555834 |
| 15 | MP0002089_abnormal_postnatal_growth/wei | 2.09919972 |
| 16 | MP0008789_abnormal_olfactory_epithelium | 2.08456006 |
| 17 | MP0005499_abnormal_olfactory_system | 2.01241985 |
| 18 | MP0005394_taste/olfaction_phenotype | 2.01241985 |
| 19 | MP0002095_abnormal_skin_pigmentation | 1.88317493 |
| 20 | MP0008877_abnormal_DNA_methylation | 1.86953286 |
| 21 | MP0000759_abnormal_skeletal_muscle | 1.85677164 |
| 22 | MP0004270_analgesia | 1.61251430 |
| 23 | MP0004087_abnormal_muscle_fiber | 1.54403171 |
| 24 | MP0005620_abnormal_muscle_contractility | 1.53625779 |
| 25 | MP0000778_abnormal_nervous_system | 1.51961825 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.51214463 |
| 27 | MP0000427_abnormal_hair_cycle | 1.50524382 |
| 28 | MP0002102_abnormal_ear_morphology | 1.43069946 |
| 29 | MP0000371_diluted_coat_color | 1.40241093 |
| 30 | MP0002106_abnormal_muscle_physiology | 1.37217958 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.35372464 |
| 32 | MP0002108_abnormal_muscle_morphology | 1.34678477 |
| 33 | MP0000372_irregular_coat_pigmentation | 1.29378679 |
| 34 | MP0002177_abnormal_outer_ear | 1.26676361 |
| 35 | MP0002009_preneoplasia | 1.26078612 |
| 36 | MP0003122_maternal_imprinting | 1.19567886 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.18932658 |
| 38 | MP0002928_abnormal_bile_duct | 1.18172293 |
| 39 | MP0001984_abnormal_olfaction | 1.15911712 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.14945148 |
| 41 | MP0008995_early_reproductive_senescence | 1.12902648 |
| 42 | MP0002938_white_spotting | 1.12625760 |
| 43 | MP0005408_hypopigmentation | 1.11023249 |
| 44 | MP0004134_abnormal_chest_morphology | 1.09217339 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.08991066 |
| 46 | MP0008057_abnormal_DNA_replication | 1.06722077 |
| 47 | MP0005083_abnormal_biliary_tract | 1.04565285 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.04076942 |
| 49 | MP0001661_extended_life_span | 1.03536453 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 0.99785948 |
| 51 | MP0005386_behavior/neurological_phenoty | 0.99773125 |
| 52 | MP0004924_abnormal_behavior | 0.99773125 |
| 53 | MP0005369_muscle_phenotype | 0.97950840 |
| 54 | MP0000733_abnormal_muscle_development | 0.96769632 |
| 55 | MP0008058_abnormal_DNA_repair | 0.94546082 |
| 56 | MP0000751_myopathy | 0.92026542 |
| 57 | MP0001293_anophthalmia | 0.91864003 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 0.91764627 |
| 59 | MP0002166_altered_tumor_susceptibility | 0.91637368 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 0.91598313 |
| 61 | MP0003959_abnormal_lean_body | 0.89871747 |
| 62 | MP0003786_premature_aging | 0.86961934 |
| 63 | MP0002971_abnormal_brown_adipose | 0.86220827 |
| 64 | MP0005253_abnormal_eye_physiology | 0.86061179 |
| 65 | MP0000631_abnormal_neuroendocrine_gland | 0.85683794 |
| 66 | MP0002075_abnormal_coat/hair_pigmentati | 0.85561370 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 0.81657943 |
| 68 | MP0003937_abnormal_limbs/digits/tail_de | 0.81545101 |
| 69 | MP0005670_abnormal_white_adipose | 0.80369958 |
| 70 | MP0001186_pigmentation_phenotype | 0.78748372 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 0.76855337 |
| 72 | MP0002751_abnormal_autonomic_nervous | 0.75967710 |
| 73 | MP0001324_abnormal_eye_pigmentation | 0.74275771 |
| 74 | MP0002896_abnormal_bone_mineralization | 0.74023388 |
| 75 | MP0000516_abnormal_urinary_system | 0.72819102 |
| 76 | MP0005367_renal/urinary_system_phenotyp | 0.72819102 |
| 77 | MP0000955_abnormal_spinal_cord | 0.71597681 |
| 78 | MP0002233_abnormal_nose_morphology | 0.70776227 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.68574422 |
| 80 | MP0005248_abnormal_Harderian_gland | 0.68098547 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.66474091 |
| 82 | MP0003755_abnormal_palate_morphology | 0.64523261 |
| 83 | MP0009046_muscle_twitch | 0.63208340 |
| 84 | MP0004484_altered_response_of | 0.62724560 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.61344107 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.60147094 |
| 87 | MP0005391_vision/eye_phenotype | 0.58921104 |
| 88 | MP0008872_abnormal_physiological_respon | 0.58914532 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.57383129 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57251172 |
| 91 | MP0002006_tumorigenesis | 0.57093418 |
| 92 | MP0000049_abnormal_middle_ear | 0.56108693 |
| 93 | MP0001440_abnormal_grooming_behavior | 0.55935816 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.54776031 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.54595571 |
| 96 | MP0002114_abnormal_axial_skeleton | 0.52908232 |
| 97 | MP0000003_abnormal_adipose_tissue | 0.52819105 |
| 98 | MP0002092_abnormal_eye_morphology | 0.51968010 |
| 99 | MP0002272_abnormal_nervous_system | 0.51731966 |
| 100 | MP0004811_abnormal_neuron_physiology | 0.51551941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 6.84332232 |
| 2 | Distal arthrogryposis (HP:0005684) | 4.79305919 |
| 3 | Nemaline bodies (HP:0003798) | 4.33220641 |
| 4 | Mask-like facies (HP:0000298) | 4.15626096 |
| 5 | Medial flaring of the eyebrow (HP:0010747) | 4.12182093 |
| 6 | Round ear (HP:0100830) | 4.12026922 |
| 7 | Congenital primary aphakia (HP:0007707) | 3.77867784 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.72718040 |
| 9 | Absent phalangeal crease (HP:0006109) | 3.70744051 |
| 10 | Gait imbalance (HP:0002141) | 3.70256472 |
| 11 | Hyperkalemia (HP:0002153) | 3.69749767 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 3.46632448 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 3.44676241 |
| 14 | Poor coordination (HP:0002370) | 3.40050871 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.38637597 |
| 16 | Abnormality of the labia minora (HP:0012880) | 3.35950486 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.34702590 |
| 18 | Nephrogenic diabetes insipidus (HP:0009806) | 3.32021306 |
| 19 | Exercise-induced muscle cramps (HP:0003710) | 3.31806728 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 3.30794373 |
| 21 | Abnormal finger flexion creases (HP:0006143) | 3.17140009 |
| 22 | Tubulointerstitial nephritis (HP:0001970) | 3.15784313 |
| 23 | Myoglobinuria (HP:0002913) | 3.11016768 |
| 24 | Albinism (HP:0001022) | 3.10706566 |
| 25 | Periorbital edema (HP:0100539) | 3.05109136 |
| 26 | Deformed tarsal bones (HP:0008119) | 2.98058693 |
| 27 | Difficulty running (HP:0009046) | 2.90556041 |
| 28 | Increased serum pyruvate (HP:0003542) | 2.88284531 |
| 29 | Facial edema (HP:0000282) | 2.87859521 |
| 30 | Menstrual irregularities (HP:0000858) | 2.84894879 |
| 31 | Oligodactyly (hands) (HP:0001180) | 2.84495905 |
| 32 | Nephronophthisis (HP:0000090) | 2.80615545 |
| 33 | Myopathic facies (HP:0002058) | 2.78324756 |
| 34 | Thyroiditis (HP:0100646) | 2.73357627 |
| 35 | Oligomenorrhea (HP:0000876) | 2.67418487 |
| 36 | Generalized hypopigmentation (HP:0007513) | 2.65360583 |
| 37 | Hepatoblastoma (HP:0002884) | 2.64482984 |
| 38 | Intestinal atresia (HP:0011100) | 2.63236635 |
| 39 | Volvulus (HP:0002580) | 2.60272258 |
| 40 | Abnormality of the renal medulla (HP:0100957) | 2.57544471 |
| 41 | Renal cortical cysts (HP:0000803) | 2.50627822 |
| 42 | Abnormality of glycolysis (HP:0004366) | 2.46888780 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 2.41962479 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.34600008 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.34600008 |
| 46 | Genital tract atresia (HP:0001827) | 2.31298077 |
| 47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.30622226 |
| 48 | Vaginal atresia (HP:0000148) | 2.29453160 |
| 49 | Increased connective tissue (HP:0009025) | 2.28169237 |
| 50 | Type 1 muscle fiber predominance (HP:0003803) | 2.26743453 |
| 51 | Partial agenesis of the corpus callosum (HP:0001338) | 2.24034108 |
| 52 | Abnormality of macular pigmentation (HP:0008002) | 2.20136411 |
| 53 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.19804152 |
| 54 | Dysdiadochokinesis (HP:0002075) | 2.17541573 |
| 55 | Gonadotropin excess (HP:0000837) | 2.16427149 |
| 56 | Abnormality of potassium homeostasis (HP:0011042) | 2.15606703 |
| 57 | Hypoplastic ischia (HP:0003175) | 2.13578429 |
| 58 | Specific learning disability (HP:0001328) | 2.10251386 |
| 59 | Myotonia (HP:0002486) | 2.09059781 |
| 60 | Abnormality of the renal cortex (HP:0011035) | 2.08364190 |
| 61 | Abnormality of the fovea (HP:0000493) | 2.08180406 |
| 62 | Long clavicles (HP:0000890) | 2.08018206 |
| 63 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.06953865 |
| 64 | Congenital stationary night blindness (HP:0007642) | 2.06838172 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.04875628 |
| 66 | Short foot (HP:0001773) | 2.04848414 |
| 67 | Fair hair (HP:0002286) | 2.03540155 |
| 68 | Neoplasm of the heart (HP:0100544) | 1.95537922 |
| 69 | Protruding tongue (HP:0010808) | 1.93309184 |
| 70 | Generalized hypopigmentation of hair (HP:0011358) | 1.93212586 |
| 71 | Genetic anticipation (HP:0003743) | 1.91144127 |
| 72 | Wrist flexion contracture (HP:0001239) | 1.88027747 |
| 73 | Agitation (HP:0000713) | 1.87325898 |
| 74 | Small hand (HP:0200055) | 1.87226299 |
| 75 | Broad foot (HP:0001769) | 1.86541404 |
| 76 | Progressive macrocephaly (HP:0004481) | 1.84443400 |
| 77 | Increased CSF lactate (HP:0002490) | 1.83531186 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 1.82739486 |
| 79 | Ventricular fibrillation (HP:0001663) | 1.82626052 |
| 80 | Hip dysplasia (HP:0001385) | 1.82270864 |
| 81 | Labial hypoplasia (HP:0000066) | 1.79878494 |
| 82 | Down-sloping shoulders (HP:0200021) | 1.79461864 |
| 83 | Left ventricular hypertrophy (HP:0001712) | 1.78728398 |
| 84 | Choroideremia (HP:0001139) | 1.77018104 |
| 85 | Iris hypopigmentation (HP:0007730) | 1.76656867 |
| 86 | Bell-shaped thorax (HP:0001591) | 1.76620736 |
| 87 | Broad-based gait (HP:0002136) | 1.75070320 |
| 88 | Hypoplastic iliac wings (HP:0002866) | 1.72887993 |
| 89 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.72192384 |
| 90 | Hypoplasia of the fovea (HP:0007750) | 1.72192384 |
| 91 | Acute necrotizing encephalopathy (HP:0006965) | 1.71768095 |
| 92 | Facial diplegia (HP:0001349) | 1.70954495 |
| 93 | Neonatal respiratory distress (HP:0002643) | 1.69786856 |
| 94 | Submucous cleft hard palate (HP:0000176) | 1.69686621 |
| 95 | Thyroid-stimulating hormone excess (HP:0002925) | 1.67436114 |
| 96 | Abnormality of the ischium (HP:0003174) | 1.67423908 |
| 97 | Medulloblastoma (HP:0002885) | 1.67353875 |
| 98 | Narrow forehead (HP:0000341) | 1.66821721 |
| 99 | Impulsivity (HP:0100710) | 1.66471868 |
| 100 | Decreased circulating renin level (HP:0003351) | 1.65801074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 3.63235400 |
| 2 | EPHA3 | 3.12600527 |
| 3 | FRK | 2.91950394 |
| 4 | CAMKK2 | 2.85714627 |
| 5 | OBSCN | 2.84419673 |
| 6 | NUAK1 | 2.72451552 |
| 7 | PHKG1 | 2.55004165 |
| 8 | PHKG2 | 2.55004165 |
| 9 | MAP3K10 | 2.24237645 |
| 10 | TRIM28 | 2.19808852 |
| 11 | DMPK | 2.13544492 |
| 12 | AKT3 | 2.03148854 |
| 13 | TIE1 | 2.02432960 |
| 14 | SGK2 | 2.01970526 |
| 15 | STK16 | 1.93021663 |
| 16 | FGFR2 | 1.90751298 |
| 17 | EPHB1 | 1.90052985 |
| 18 | BRSK2 | 1.86689413 |
| 19 | MARK3 | 1.77404604 |
| 20 | SIK3 | 1.76673101 |
| 21 | PDK2 | 1.74554178 |
| 22 | MAP3K4 | 1.59872287 |
| 23 | CCNB1 | 1.54420105 |
| 24 | BCKDK | 1.49938771 |
| 25 | CAMK1G | 1.48884520 |
| 26 | SGK494 | 1.45787009 |
| 27 | SGK223 | 1.45787009 |
| 28 | MAP2K7 | 1.41613535 |
| 29 | IRAK1 | 1.30733583 |
| 30 | CAMK1D | 1.29850806 |
| 31 | TYRO3 | 1.27291011 |
| 32 | MAP4K2 | 1.26683593 |
| 33 | MST4 | 1.19210671 |
| 34 | RAF1 | 1.10516193 |
| 35 | SGK3 | 1.09269820 |
| 36 | PKN2 | 1.07948054 |
| 37 | DYRK3 | 1.05080526 |
| 38 | BRD4 | 1.01783853 |
| 39 | TAOK1 | 0.97761498 |
| 40 | FGFR3 | 0.97324637 |
| 41 | GRK1 | 0.95842453 |
| 42 | WNK4 | 0.94722457 |
| 43 | CAMKK1 | 0.94480256 |
| 44 | PINK1 | 0.92338968 |
| 45 | PIK3CA | 0.91750838 |
| 46 | WNK1 | 0.91397378 |
| 47 | FGFR1 | 0.87334205 |
| 48 | MAPK13 | 0.86258975 |
| 49 | ACVR1B | 0.85558092 |
| 50 | PRKG1 | 0.83873874 |
| 51 | VRK1 | 0.83477098 |
| 52 | STK11 | 0.83154581 |
| 53 | CHEK2 | 0.79273343 |
| 54 | TEC | 0.77928572 |
| 55 | SRPK1 | 0.75988041 |
| 56 | MAP3K6 | 0.75332151 |
| 57 | CAMK1 | 0.75025750 |
| 58 | LIMK1 | 0.73293735 |
| 59 | BCR | 0.69966751 |
| 60 | MARK2 | 0.68743396 |
| 61 | ILK | 0.66743463 |
| 62 | CHUK | 0.66245768 |
| 63 | ERBB3 | 0.65616705 |
| 64 | NTRK3 | 0.65581272 |
| 65 | CASK | 0.65566066 |
| 66 | MAP3K14 | 0.65490489 |
| 67 | BMPR1B | 0.64605199 |
| 68 | CAMK4 | 0.61587382 |
| 69 | DAPK2 | 0.61493201 |
| 70 | OXSR1 | 0.61223596 |
| 71 | PIK3CG | 0.56813244 |
| 72 | MAP2K4 | 0.56777675 |
| 73 | NLK | 0.56551700 |
| 74 | BRSK1 | 0.54672053 |
| 75 | TAF1 | 0.53048566 |
| 76 | EIF2AK3 | 0.52729868 |
| 77 | RPS6KA4 | 0.50820168 |
| 78 | CDK3 | 0.49307923 |
| 79 | PIM1 | 0.49256992 |
| 80 | MARK1 | 0.48919878 |
| 81 | PRKAA1 | 0.46878533 |
| 82 | ATR | 0.45248322 |
| 83 | CDK9 | 0.43494280 |
| 84 | DYRK1B | 0.43454560 |
| 85 | JAK3 | 0.43425357 |
| 86 | PLK3 | 0.41408815 |
| 87 | BMPR2 | 0.40098934 |
| 88 | ATM | 0.39136447 |
| 89 | PRKACB | 0.38372623 |
| 90 | FER | 0.35286165 |
| 91 | PRKCE | 0.35044132 |
| 92 | CAMK2G | 0.34957054 |
| 93 | SGK1 | 0.34357866 |
| 94 | PRKACA | 0.33066834 |
| 95 | CSNK1G1 | 0.32813276 |
| 96 | CDK4 | 0.31828301 |
| 97 | TESK1 | 0.29555002 |
| 98 | CSNK1A1L | 0.28833916 |
| 99 | NTRK2 | 0.28604540 |
| 100 | PASK | 0.27751519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of autophagy_Homo sapiens_hsa04140 | 5.53227455 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.82465360 |
| 3 | RNA degradation_Homo sapiens_hsa03018 | 2.77403674 |
| 4 | Tight junction_Homo sapiens_hsa04530 | 2.63061263 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.57640922 |
| 6 | Circadian rhythm_Homo sapiens_hsa04710 | 2.55704059 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31884482 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22455611 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.10990323 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97267472 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89064699 |
| 12 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.74942346 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.72917540 |
| 14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.58874778 |
| 15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52576365 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45903299 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.42160317 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.41788551 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41656655 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41129151 |
| 21 | Proteasome_Homo sapiens_hsa03050 | 1.39246785 |
| 22 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.37399499 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.32475015 |
| 24 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.32256684 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.29631837 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.29049722 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28123336 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23334818 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17627010 |
| 30 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.17499211 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13848006 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12957860 |
| 33 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.11884664 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08694341 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06263678 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03050894 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99469396 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.98146422 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97448589 |
| 40 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95429419 |
| 41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93670479 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92663485 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91689991 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88942845 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87788017 |
| 46 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87356144 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85378913 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85298104 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 0.84814082 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84057774 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.82605240 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80562750 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.80093666 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 0.79954844 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79871301 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79354458 |
| 57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78752034 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78325843 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78011980 |
| 60 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75322713 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74962798 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74042389 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71529571 |
| 64 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.66794805 |
| 65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65919863 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.65035219 |
| 67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58088115 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58006630 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56452330 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.56294824 |
| 71 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55783711 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53891418 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53737031 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51788865 |
| 75 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51401441 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.50573548 |
| 77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50065653 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.49594896 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48163684 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45882501 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43746053 |
| 82 | Spliceosome_Homo sapiens_hsa03040 | 0.43015398 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42542983 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.38371733 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38096964 |
| 86 | Alcoholism_Homo sapiens_hsa05034 | 0.37960493 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37611797 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37193072 |
| 89 | Salivary secretion_Homo sapiens_hsa04970 | 0.36580246 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.31414745 |
| 91 | Mismatch repair_Homo sapiens_hsa03430 | 0.31407242 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28978917 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.28338996 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28148144 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.26866408 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.26840791 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26833675 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.26482197 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.25858148 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.23612709 |

